Acid shingomyelinase in macrophage apoptosis

Current Opinion in Lipidology

Volumn 15, Issue 5, 2004, Pages 531-537

  Steinbrecher, Urs P ^a,c   Gómez Muñoz, Antonio ^b   Duronio, Vincent ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^c Division of Gastroenterology   (Canada)

Author keywords

Apoptosis; Atherosclerosis; Ceramide; Macrophages; Oxidized LDL; Protein kinase B Akt; Signal transduction; Sphingomyelinase

Indexed keywords

CASPASE 3; CERAMIDE; GROWTH FACTOR; OXIDIZED LOW DENSITY LIPOPROTEIN; PROTEIN KINASE B; SPHINGOLIPID; SPHINGOMYELIN; SPHINGOMYELIN PHOSPHODIESTERASE;

APOPTOSIS; ATHEROSCLEROTIC PLAQUE; BONE MARROW; CELL MEMBRANE; CONCENTRATION RESPONSE; ENZYME ACTIVATION; HUMAN; LIPOGENESIS; LYSOSOME; MACROPHAGE; MACROPHAGE FUNCTION; MITOCHONDRION; NECROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; ARTERIOSCLEROSIS; BIOLOGICAL MODEL; CELL PROLIFERATION; CELL SURVIVAL; INFLAMMATION; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ANIMALS; APOPTOSIS; ARTERIOSCLEROSIS; CELL PROLIFERATION; CELL SURVIVAL; HUMANS; INFLAMMATION; MACROPHAGES; MODELS, BIOLOGICAL; SIGNAL TRANSDUCTION; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOMYELINS;

EID: 5044223161     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041433-200410000-00006     Document Type: Review

References (72)

1. Stary H, Chandler A, Dinsmore R, et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. Arterioscler Thromb Vasc Biol 1995; 15:1512-1531.
2. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999; 340:115-126.
3. Hamilton JA. Nondisposable materials, chronic inflammation, and adjuvant action. J Leukoc Biol 2003; 73:702-712.
4. Hannun YA, Obeid LM. Ceramide: an intracellular signal for apoptosis. Trends Biochem Sci 1995; 20:73-77.
5. Kolesnick R, Golde DW. The sphingomyelinase pathway in tumor necrosis factor and interleukin-1 signaling. Cell 1994; 77:325-328.
6. Gómez-Mun̄oz A. Modulation of cell signalling by ceramides. Biochim Biophys Acta 1998; 1391:92-109.
7. Ballou LR, Laulederkind SJ, Rosloniec EF, Raghow R. Ceramide signalling and the immune response. Biochim Biophys Acta 1996; 1301:273-287.
8. Hannun Y. The sphingomyelin cycle and the second messenger function of ceramide. J Biol Chem 1994; 269:3125-3128.
9. Hannun YA, Obeid LM. The ceramide-centric universe of lipid-mediated cell regulation: stress encounters of the lipid kind. J Biol Chem 2002; 277:25847-25850.
10. Gon̄i FM, Alonso A. Sphingomyelinases: enzymology and membrane activity. FEBS Lett 2002; 531:38-46.
11. Cremesti AE, Goñi FM, Kolesnick RN. Role of sphingomyelin and ceramide in modulating rafts: do biophysical properties determine biologic outcome? FEBS Lett 2002; 531:47-53.
12. Grassmé H, Cremesti A, Kolesnick R, Gulbins E. Ceramide-mediated clustering is required for CD95-DISC formation. Oncogene 2003; 22:5457-5470.
13. Vit JP, Rosselli F. Role of the ceramide-signaling pathways in ionizing radiation-induced apoptosis. Oncogene 2003; 22:8645-8652.
14. Watanabe M, Kitano T, Kondo T, et al. Increase of nuclear ceramide through caspase-3-dependent regulation of the 'sphingomyelin cycle' in Fas-induced apoptosis. Cancer Res 2004; 64:1000-1007.
15. Kolesnick RN, Hemer MR. Characterization of a ceramide kinase activity from human leukemia (HL-60) cells. J Biol Chem 1990; 265:18803-18808.
16. Dobrowsky RT, Kamibayashi C, Mumby MC, Hannun YA. Ceramide activates heterotrimeric protein phosphatase 2A. J Biol Chem 1993; 268:15523-15530.
17. Lozano J, Berra E, Municio M, et al. Protein kinase C zeta isoform is critical for kappa B-dependent promoter activation by sphingomyelinase. J Biol Chem 1994; 269:19200-19202.
18. Verheij M, Bose R, Lin XH, et al. Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature 1996; 380:75-79.
19. Westwick JK, Bielawska AE, Dbaibo G, et al. Ceramide activates the stress-activated protein kinases. J Biol Chem 1995; 270:22689-22692.
20. Yao R, Cooper GM. Requirement for phosphatidylinositol 3-kinase in the prevention of apoptosis by nerve growth factor. Science 1995; 267:2003-2006.
21. Hayakawa M, Jayadev S, Tsujimoto M, et al. Role of ceramide in stimulation of the transcription of cytosolic phospholipase A2 and cyclooxygenase 2. Biochem Biophys Res Commun 1996; 220:681-686.
22. Bourbon NA, Sandirasegarane L, Kester M. Ceramide-induced inhibition of Akt is mediated through protein kinase Czeta: implications for growth arrest. J Biol Chem 2002; 277:3286-3292.
23. Schubert KM, Scheid MP, Duronio V. Ceramide inhibits protein kinase B/Akt by promoting dephosphorylation of serine 473. J Biol Chem 2000; 275:13330-13335.
24. Gómez-Muñoz A, Martin A, O'Brien L, Brindley DN. Cell-permeable ceramides inhibit the stimulation of DNA synthesis and phospholipase D activity by phosphatidate and lysophosphatidate in rat fibroblasts. J Biol Chem 1994; 269:8937-8943.
25. Gómez-Muñoz A, Waggoner DW, O'Brien L, Brindley DN. Interaction of ceramides, sphingosine, and sphingosine 1-phosphate in regulating DNA synthesis and phospholipase D activity. J Biol Chem 1995; 270:26318-26325.
26. Jamal Z, Martin A, Gomez-Muñoz A, Brindley DN. Plasma membrane fractions from rat liver contain a phosphatidate phosphohydrolase distinct from that in the endoplasmic reticulum and cytosol. J Biol Chem 1991; 266:2988-2996.
27. Gómez-Muñoz A, Hamza EH, Brindley DN. Effects of sphingosine, albumin and unsaturated fatty acids on the activation and translocation of phosphatidate phosphohydrolases in rat hepatocytes. Biochim Biophys Acta 1992; 1127:49-56.
28. Hannun YA, Loomis CR, Merrill AHJ, Bell RM. Sphingosine inhibition of protein kinase C activity and of phorbol dibutyrate binding in vitro and in human platelets. J Biol Chem 1986; 261:12604-12609.
29. Natarajan V, Jayaram HN, Scribner WM. Activation of endotheliai cell phospholipase D by sphingosine and sphingosine 1-phosphate. Am J Respir Cell Mol Biol 1994; 11:221-229.
30. Yamada K, Sakane F, Imai S, Takemura H. Sphingosine activates cellular diacylglycerol kinase in intact Jurkat cells, a human T-cell line. Biochim Biophys Acta 1993; 1169:217-224.
31. Desai N, Zhang H, Olivera A, et al. Sphingosine-1-phosphate, a metabolite of sphingosine, increases phosphatidic acid levels by phospholipase D activation. J Biol Chem 1992; 267:122-128.
32. Zhang H, Desai NN, Olivera A, et al. Sphingosine-1-phosphate, a novel lipid, involved in cellular proliferation. J Cell Biol 1991; 114:155-167.
33. Ancellin N, Colmont C, Su J, et al. Extracellular export of sphingosine kinase-1 enzyme: sphingosine 1-phosphate generation and the induction of angiogenic vascular maturation. J Biol Chem 2002; 277:6667-6675.
34. Merrill AHJ. De novo sphingolipid biosynthesis: a necessary, but dangerous, pathway. J Biol Chem 2002; 277:25843-25846.
35. Payne SG, Milstien S, Spiegel S. Sphingosine-1-phosphate: dual messenger functions. FEBS Lett 2002; 531:54-57.
36. Gómez-Mun̄oz A, Kong J, Salh B, Steinbrecher U. Sphingosine 1-phosphate inhibits acid sphingomyelinase and blocks apoptosis in macrophages. FEBS Lett 2003; 536:56-60.
37. Rabano M, Peña A, Brizuela L, et al. Sphingosine-1-phosphate stimulates cortisol secretion. FEBS Lett 2003; 535:101-105.
38. Vann LR, Payne SG, Edsall LC, et al. Involvement of sphingosine kinase in TNF-alpha-stimulated tetrahydrobiopterin biosynthesis in C6 glioma cells. J Biol Chem 2002; 277:12649-12656.
39. Gómez-Muñoz A, Duffy PA, Martin A, et al. Short-chain ceramide-1-phosphates are novel stimulators of DNA synthesis and cell division: antagonism by cell-permeable ceramides. Mol Pharmacol 1995; 47:883-889.
40. Gómez-Mun̄oz A, Frago L, Alvarez L, Varela-Nieto I. Stimulation of DNA synthesis by natural ceramide 1-phosphate. Biochem J 1997; 325:435-440.
41. Gómez-Mun̄oz A, Kong J, Salh B, Steinbrecher U. Ceramide-1-phosphate blocks apoptosis through inhibitbn of acid sphingomyelinase in macrophages. J Lipid Res 2004; 45:99-105.
42. Hinkovska-Galcheva VT, Boxer LA, Mansfield PJ, et al. The formation of ceramide-1-phosphate during neutrophil phagocytosis and its role in liposome fusion. J Biol Chem 1998; 273:333203-333209.
43. Pettus BJ, Bielawska A, Spiegel S, et al. Ceramide kinase mediates cytokine-and calcium ionophore-induced arachidonic acid release. J Biol Chem 2003; 278:38206-38213.
44. Pettus BJ, Bielawska A, Subramanian P, et al. Ceramide 1-phosphate is a direct activator of cytosolic phospholipase A2. J Biol Chem 2004; 279:11320-11326.
45. Rile G, Yatomi Y, Takafuta T, Ozaki Y. Ceramide 1-phosphate formation in neutrophils. Acta Haematol 2003; 109:76-83.
46. Okazaki T, Bielawska A, Bell RM, Hannun YA. Role of ceramide as a lipid mediator of 1 alpha,25-dihydroxyvitamin D3-induced HL-60 cell differentiation. J Biol Chem 1990; 265:15823-15831.
47. Kim M, Linardic C, Obeid L, Hannun Y. Identification of sphingomyelin turnover as an effector mechanism for the action of tumor necrosis factor alpha and gamma-interferon: specific role in cell differentiation. J Biol Chem 1991; 266:484-489.
48. Raines M, Kolesnick R, Golde D. Sphingomyelinase and ceramide activate mitogen-activated protein kinase in myeloid HL-60 cells. J Biol Chem 1993; 268:14572-14575.
49. Medvedev AE, Blanco JCG, Qureshi N, Vogel SN. Limited role of ceramide in lipopolysaccharide-mediated mitogen-activated protein kinase activation, transcription factor induction, and cytokine release. J Biol Chem 1999; 274:9342-9350.
50. Muller G, Ayoub M, Storz P, et al. PKC zeta is a molecular switch in signal transduction of TNF-alpha, bifunctionally regulated by ceramide and arachidonic acid. EMBO J 1995; 14:1961-1969.
51. Monick MM, Carter AB, Gudmundsson G, et al. A phosphatidylcholine- specific phospholipase C regulates activation of p42/44 mitogen-activated protein kinases in lipopolysaccharide-stimulated human alveolar macrophages. J Immunol 1999; 162:3005-3012.
52. Procyk KJ, Rippo MR, Testi R, et al. Lipopolysaccharide induces Jun N-terminal kinase activation in macrophages by a novel Cdc42/Rac-independent pathway involving sequential activation of protein kinase C zeta and phosphatidylcholine-dependent phospholipase C. Blood 2000; 96:2592-2598.
53. Cho YH, Lee CH, Kim SG. Potentiation of lipopolysaccharide-inducible cyclooxygenase 2 expression by C2-ceramide via c-Jun N-terminal kinase-mediated activation of CCAAT/enhancer binding protein beta in macrophages. Mol Pharmacol 2003; 63:512-523.
54. Laouar A, Glesne D, Huberman E. Involvement of protein kinase C-beta and ceramide in tumor necrosis factor-alpha-induced but not Fas-induced apoptosis of human myeloid leukemia cells. J Biol Chem 1999; 274:23526-23534.
55. Laouar A, Glesne D, Huberman E. Protein kinase C-beta, fibronectin, alpha(5)beta(1)-integrin, and tumor necrosis factor-alpha are required for phorbol diester-induced apoptosis in human myeloid leukemia cells. Mol Carcinog 2001; 32:195-205.
56. Dhami R, He X, Gordon RE, Schuchman EH. Analysis of the lung pathology and alveolar macrophage function in the acid sphingomyelinase-deficient mouse model of Niemann-Pick disease. Lab Invest 2001; 81:987-999.
57. Spiegel S, Milstien S. Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat Rev Mol Cell Biol 2003; 4:397-407.
58. Kockx MM. Apoptosis in the atherosclerotic plaque: quantitative and qualitative aspects. Arterioscler Thromb Vasc Biol 1998; 18:1519-1522.
59. Katsuda S, Coltrera MD, Ross R, Gown AM. Human atherosclerosis. IV: Immunocytochemical analysis of cell activation and proliferation in lesions of young adults. Am J Pathol 1993; 142:1787-1793.
60. Kockx MM, De Meyer GR, Buyssens N, et al. Cell composition, replication, and apoptosis in atherosclerotic plaques after 6 months of cholesterol withdrawal. Circ Res 1998; 83:378-387.
61. Shiomi M, Ito T, Tsukada T, et al. Reduction of serum cholesterol levels alters lesional composition of atherosclerotic plaques: effect of pravastatin sodium on atherosclerosis in mature WHHL rabbits. Arterioscler Thromb Vasc Biol 1995; 15:1938-1944.
62. Hamilton JA, Myers D, Jessup W, et al. Oxidized LDL can induce macrophage survival, DNA synthesis, and enhanced proliferative response to CSF-1 and GM-CSF. Arterioscler Thromb Vasc Biol 1999; 19:98-105.
63. Hundal R, Salh B, Schrader J, et al. Oxidized low density lipoprotein inhibits macrophage apoptosis through activation of the PI 3-kinase/PKB pathway. J Lipid Res 2001; 42:1483-1491.
64. Hundal R, Gómez-Muñoz A, Salh B, et al. Oxidized low density lipoprotein inhibits macrophage apoptosis by blocking ceramide generation, thereby maintaining PKB activation and Bcl-XL levels. J Biol Chem 2003; 278:24399-24408.
65. Salvayre R, Auge N, Benoist H, Negre-Salvayre A. Oxidized low-density lipoprotein-induced apoptosis. Biochim Biophys Acta 2002; 1585:213-221.
66. Bjorkerud B, Bjorkerud S. Contrary effects of lightly and strongly oxidized LDL with potent promotion of growth versus apoptosis on arterial smooth muscle cells, macrophages, and fibroblasts. Arterioscl Thromb Vasc Biol 1996; 16:416-424.
67. Han CY, Pak YK. Oxidation-dependent effects of oxidized LDL: proliferation or cell death. Exp Mol Med 1999; 31:165-173.
68. Asmis R, Begley JG. Oxidized LDL promotes peroxide-mediated mitochondrial dysfunction and cell death in human macrophages: a caspase-3-independent pathway. Circ Res 2003; 92:e20-e29.
69. Nhan TQ, Liles WC, Chait A, et al. The p17 cleaved form of caspase-3 is present within viable macrophages in vitro and in atherosclerotic plaque. Arterioscler Thromb Vasc Biol 2003; 23:1276-1282.
70. Deigner H, Claus R, Bonaterra G, et al. Ceramide induces aSMase expression: implications for oxLDL-induced apoptosis. FASEB J 2001; 15:807-814.
71. Loidl A, Sevcsik E, Riesenhuber G, et al. Oxidized phospholipids in minimally modified low density lipoprotein induce apoptotic signaling via activation of acid sphingomyelinase in arterial smooth muscle cells. J Biol Chem 2003; 278:32921-32928.
72. Kitatani K, Nemoto M, Akiba S, Sato T. Stimulation by de novo-synthesized ceramide of phospholipase A2-dependent cholesterol esterification promoted by the uptake of oxidized low-density lipoprotein in macrophages. Cell Signal 2002; 14:695-701.